Foot News and Research

RSS

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

BioMedical Enterprises announced the launch of the Speed Titan Nitinol Bone Fixation Implant today. As the newest addition to the BME Speed Fixation System, the Speed Titan joins the BME Speed, Speed Arc and Speed Shift™ implants to create the world's most comprehensive family of continuous active compression Nitinol implants.

1 Apr 2015

Uganda Newborn Study explores ways to improve child mortality rates

In Uganda, child mortality rates are improving, but progress is slower for deaths occurring in the first four weeks of life, or the newborn period, and for stillbirths. But recent evidence from local researchers show that a cost-effective package of care linking families, government-mandated village health teams (a form of community health workers), and health facilities can improve life-saving practices during pregnancy, childbirth and in the first weeks of life; and benefit poorest families the most.

1 Apr 2015

C3BS plans to open new U.S.-based facility to manufacture C-Cure for use in Phase III trial

Cardio3 BioSciences, a leader in the discovery and development of engineered cell therapies, today confirmed plans to open a new U.S.-based manufacturing facility in Rochester, Minnesota. The facility will support the Company’s current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure (CHART-2), and its recently acquired CAR T-cell therapies’ portfolio.

26 Mar 2015

HRQoL benefit of alternative sunitinib dosing schedule in RCC patients

Patients with metastatic renal cell carcinoma reported a marked improvement in their health-related quality of life when given sunitinib on a 2 weeks on and 1 week off schedule compared with a 4 weeks on and 2 weeks off regimen, a Japanese study finds.

25 Mar 2015

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today announced operational, clinical and financial results for the year ended December 31, 2014.

24 Mar 2015

GenVec reports record financial results for Q4 and fiscal year 2014

GenVec, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the year ended December 31, 2014, the company reported a net loss of $2.5 million, or $0.16 per share, compared with a net loss of $10.0 million, or $0.77 per share, for the year ended December 31, 2013.

24 Mar 2015

Maintaining heel-toe pattern while running barefoot may lead to frequent injuries in older athletes

In recent years there has been an explosion in barefoot running, as well as the purchase and use of "minimalist" running shoes that more closely resemble barefoot running by encouraging the balls of the feet, between the arch and toes, to hit the pavement first.

24 Mar 2015

UZH researchers map spinal cord neurons involved in 'Gate Control Theory' of pain

Sensing pain is extremely unpleasant and sometimes hard to bear - and pain can even become chronic. The perception of pain varies a lot depending on the context in which it is experienced. 50 years ago, neurobiologist Patrick Wall and psychologist Ronald Melzack formulated the so-called "Gate Control Theory" of pain.

20 Mar 2015

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

New animal studies at Henry Ford Hospital found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in relieving painful and potentially life-threatening nerve damage in men with long-term diabetes.

18 Mar 2015

TCC-EZ Casting System dramatically increases healing process of diabetic foot ulcers

Diabetics once facing the prospect of amputation to their lower limbs due to the effects of foot ulcers are now back on their feet thanks to a new technology.

18 Mar 2015

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

Kennedy Funding Financial LLC has completed a $3.5 million loan for Lifestyle Real Estate I, LP, announced Gregg Wolfer, COO of the Englewood Cliffs, NJ-based direct private lender. The borrower is an affiliate of Lifestyle Healthcare Group (LHG), and the collateral is a 10.31-acre tract of vacant land in Bensalem Twp., Bucks County, PA. LHG has received approval from the township for a $185 million medical office campus.

17 Mar 2015

New study finds no connection between hip width and efficient locomotion

Among the facts so widely assumed that they are rarely, if ever studied, is the notion that wider hips make women less efficient when they walk and run.

13 Mar 2015

New medical innovations to be presented at Royal Society of Medicine summit

A super-slim wearable sensor developed by sixteen-year old school student Kenneth Shinozuka from the US will be one of the highlights at the Spring medical innovations summit at the Royal Society of Medicine on Saturday 18 April.

11 Mar 2015

18F-fluoride PET/MR imaging could diagnose cause of foot pain better than other methods

A single scan could diagnose the cause of foot pain better and with less radiation exposure to the patient than other methods, according to a study in the March 2015 issue of The Journal of Nuclear Medicine.

10 Mar 2015

Non-viral gene therapy provides relief for diabetics with constant foot pain

Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades.

6 Mar 2015

Nottingham researchers developing mobile phone app that could help identify premature babies

A mobile phone app that will identify babies born prematurely in the developing world is being developed by researchers at The University of Nottingham.

2 Mar 2015

BioMed Realty recaptures valuable properties in Cambridge innovation district

BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has recaptured approximately 313,000 square feet of space in the most dynamic and valuable life science real estate market in the world through the termination of Vertex Pharmaceuticals' leases on three properties in Cambridge, Massachusetts effective February 28, 2015.

2 Mar 2015

Novel technology could improve diagnosis of peripheral arterial disease

Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is caused by narrowing of the arteries as a result of plaque buildup. The plaque accumulation leads to an insufficient blood flow to the body's extremities and increases a person's risk for heart attack and stroke by up to six times. PAD is also one of the most serious complications of diabetes.

26 Feb 2015

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

23 Feb 2015

Researchers reveal how C. difficile wreaks havoc on guts, causes life-threatening diseases

In a new paper in the journal Infection and Immunity, the researchers lay out for the first time exactly how C. difficile wreaks havoc on the guts of animals in a short time, and causes severe diarrhea and life-threatening disease in humans.

19 Feb 2015

Foot News and Research

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

Uganda Newborn Study explores ways to improve child mortality rates

C3BS plans to open new U.S.-based facility to manufacture C-Cure for use in Phase III trial

HRQoL benefit of alternative sunitinib dosing schedule in RCC patients

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

GenVec reports record financial results for Q4 and fiscal year 2014

Maintaining heel-toe pattern while running barefoot may lead to frequent injuries in older athletes

UZH researchers map spinal cord neurons involved in 'Gate Control Theory' of pain

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

TCC-EZ Casting System dramatically increases healing process of diabetic foot ulcers

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

New study finds no connection between hip width and efficient locomotion

New medical innovations to be presented at Royal Society of Medicine summit

18F-fluoride PET/MR imaging could diagnose cause of foot pain better than other methods

Non-viral gene therapy provides relief for diabetics with constant foot pain

Nottingham researchers developing mobile phone app that could help identify premature babies

BioMed Realty recaptures valuable properties in Cambridge innovation district

Novel technology could improve diagnosis of peripheral arterial disease

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Researchers reveal how C. difficile wreaks havoc on guts, causes life-threatening diseases

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News